×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Rosenberg Noah L.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerAug 17, 2021Sale$17.121,40724,08547,614Aug 17, 2021, 07:39 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerJul 28, 2021Sale$13.811,25017,26344,521Jul 29, 2021, 04:09 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerFeb 05, 2021Sale$31.411,12535,33647,469Feb 09, 2021, 04:32 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerFeb 08, 2021Sale$31.581,12535,52746,344Feb 09, 2021, 04:32 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerFeb 03, 2021Sale$28.911,81352,41444,657Feb 03, 2021, 09:33 PM
TVTXTravere Therapeutics, Inc.Rosenberg Noah L.Chief Medical OfficerFeb 02, 2021Sale$30.751,81355,75046,470Feb 02, 2021, 09:31 PM
RTRXRetrophin, Inc.Rosenberg Noah L.Chief Medical OfficerSep 23, 2020Sale$18.4875013,86027,555Sep 23, 2020, 08:00 PM
RTRXRetrophin, Inc.Rosenberg Noah L.Chief Medical OfficerSep 22, 2020Sale$18.5975013,94328,305Sep 22, 2020, 09:20 PM
RTRXRetrophin, Inc.Rosenberg Noah L.Chief Medical OfficerJul 28, 2020Sale$20.4987017,82626,055Jul 30, 2020, 07:48 PM
RTRXRetrophin, Inc.Rosenberg Noah L.Chief Medical OfficerMay 12, 2020Sale$16.985278,95126,728May 13, 2020, 09:00 PM
RTRXRetrophin, Inc.Rosenberg Noah L.Chief Medical OfficerMar 05, 2020Sale$15.361,79027,48727,255Mar 09, 2020, 09:05 PM
RTRXRetrophin, Inc.Rosenberg Noah L.Chief Medical OfficerJul 30, 2019Sale$19.821,25024,77514,750Jul 31, 2019, 09:15 PM
RTRXRetrophin, Inc.Rosenberg Noah L.Chief Medical OfficerJul 31, 2019Sale$20.071,25025,08713,500Jul 31, 2019, 09:15 PM